VANCOUVER, Sept. 18 /CNW/ - Neovasc Inc. (TSXV: NVC), a new specialty
vascular device company, today announced that chief executive officer Alexei
Marko will present at the upcoming UBS Global Life Sciences Conference at 2:00
pm EDT on September 25, 2008. The conference will be held at the Grand Hyatt
Hotel in New York City.
The audio portion of the company's presentation will be webcast live. It
can be accessed at the Investors section of the Neovasc website at
www.neovasc.com. An archived version of the webcast will be available for
30 days beginning three hours after the start of the presentation.
For more information about the 2008 UBS Global Life Sciences Conference,
About Neovasc Inc.
Neovasc Inc. (formerly Medical Ventures Corp.), is a new specialty
vascular device company that develops, manufactures and markets medical
devices for the rapidly growing vascular and surgical marketplace. Neovasc is
comprised of the former Medical Ventures Corp., Neovasc Medical Ltd. and
B-Balloon Ltd. The company's current products include, Metricath(R) for
intravascular measurement and PeriPatch(TM) surgical tissue and staple line
reinforcement products. Neovasc has a development pipeline of innovative new
products, and provides contract medical device development and manufacturing
services. For more information, visit: www.neovasc.com.
For further information:
For further information: Corporate contact: Neovasc Inc., Chris Clark,
(604) 248-4138; U.S. media & investor contact: GendeLLindheim BioCom Partners,
Barbara Lindheim, (212) 918-4650